SELLAS Life Sciences Group (SLS) Operating Income: 2020-2023
Historic Operating Income for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to -$8.2 million.
- SELLAS Life Sciences Group's Operating Income rose 13.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 9.73%. This contributed to the annual value of -$37.9 million for FY2023, which is 9.73% up from last year.
- SELLAS Life Sciences Group's Operating Income amounted to -$8.2 million in Q4 2023, which was up 12.65% from -$9.4 million recorded in Q3 2023.
- SELLAS Life Sciences Group's Operating Income's 5-year high stood at -$2.2 million during Q1 2021, with a 5-year trough of -$16.7 million in Q1 2022.
- In the last 3 years, SELLAS Life Sciences Group's Operating Income had a median value of -$8.8 million in 2022 and averaged -$8.8 million.
- Per our database at Business Quant, SELLAS Life Sciences Group's Operating Income spiked by 44.76% in 2021 and then plummeted by 645.43% in 2022.
- Over the past 4 years, SELLAS Life Sciences Group's Operating Income (Quarterly) stood at -$4.2 million in 2020, then plummeted by 179.37% to -$11.6 million in 2021, then increased by 18.70% to -$9.4 million in 2022, then grew by 13.43% to -$8.2 million in 2023.
- Its Operating Income stands at -$8.2 million for Q4 2023, versus -$9.4 million for Q3 2023 and -$9.1 million for Q2 2023.